Fidelity Investments’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Fidelity Investments’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$112K	Buy	3,923 +3,817	+3,601%	+$111K	﹤0.01%	3747
2025 Q4	$3.01K	Hold	106	–	–	﹤0.01%	4974
2025 Q3	$2.97K	Hold	106	–	–	﹤0.01%	4885
2025 Q2	$2.79K	Hold	106	–	–	﹤0.01%	4811
2025 Q1	$2.68K	Sell	106 -107	-50%	-$2.72K	﹤0.01%	4835
2024 Q4	$5.26K	Hold	213	–	–	﹤0.01%	4663
2024 Q3	$5.4K	Buy	+213	New	+$5.18K	﹤0.01%	4610
2022 Q1	–	Sell	-1	Closed	–	–	5395
2021 Q4	$0	Buy	+1	New	+$21	﹤0.01%	4836

Other funds holding REVS

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Ruggaard & Associates Hudson, Ohio $252M AUM 14.53% 1-Year Est. Return

WIA

World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Fidelity Investments's REVS Position: Q1 2026 in Review

Fidelity Investments increased its Columbia Research Enhanced Value ETF (REVS) stake by 3,601% in Q1 2026, buying an estimated $111K and bringing the position to 3,923 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #3747.

Fidelity Investments first reported a position in REVS in Q4 2021 and has held it in 8 quarters since. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.

Fidelity Investments held 3,923 shares of Columbia Research Enhanced Value ETF worth $112K as of Q1 2026.
Fidelity Investments bought 3,817 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $111K.
Columbia Research Enhanced Value ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3747 holding.
Fidelity Investments first reported a position in Columbia Research Enhanced Value ETF in Q4 2021 and has held it in 8 quarters since.
37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.